Basic Information
ID DDInter1172
Drug Type small molecule
Molecular Formula C11H15NO5
Molecular Weight 241.241
CAS Number 532-03-6
Description Methocarbamol was developed in the early 1950s as a treatment for muscle spasticity and the associated pain.[A178441,A178450] It is a guaiacol glyceryl ether.[A178450] Methocarbamol tablets and intramuscular injections are prescription medicines indicated in the United States as an adjunct to rest, physical therapy, and other measures for the relief of discomforts associated with acute, painful musculoskeletal conditions.[Label,L6268] In Canada, methocarbamol can be sold as an over the counter oral medicine at a lower dose that may be combined with [acetaminophen] or [ibuprofen].[L6295] A combination product with [acetylsalicylic acid] and [codeine] is available in Canada by prescription.[L6295] Methocarbamol was FDA approved on 16 July 1957.[L6265]
ATC Classification M03BA73 M03BA03 M03BA53
IUPAC Name 2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate
InChI GNXFOGHNGIVQEH-UHFFFAOYSA-N
Canonical SMILES COC1=C(OCC(O)COC(N)=O)C=CC=C1
Useful Links DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB PharmGKB Wikipedia ChEMBL
Interactions with Methocarbamol
Filter:
Severity level ID Name Mechanism Detail
Interactions with diseases
Filter:
Severity level Disease name Text References
Interactions with foods
Filter:
Severity level Food name Description Management Mechanism References
Interactions with compound preparation
Multi-DRUG trade Multi-DRUG Drug type Warning Note